Border Buffers

Protected areas help to conserve imperiled tropical forests, but many are struggling to sustain their resident species.

Written byWilliam Laurance
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

POACHED: A young elephant shot by poachers near Rabi Reserve in southern Gabon. Although it has a bullet wound in its skull, the elephant evidently escaped and later died, because its tusks haven’t been removed.© RALPH BUIJYou couldn’t have witnessed the terrible carnage at Bouba N’Djida National Park in Cameroon and not be alarmed about the future of biodiversity. In March 2012, armed poachers invaded the park and slaughtered more than half of its 400 forest elephants for their valuable ivory tusks.

Fortunately, not all protected areas are suffering such incursions. In the Brazilian Amazon, where I’ve worked as an ecologist for the past 17 years, parks are helping to slow illegal logging and forest burning in vulnerable frontier areas. Likewise, in northeastern India, my doctoral student Nandini Velho is finding that protected parks are doing a much better job than surrounding community lands in sustaining vulnerable wildlife such as tigers.

Protected areas now span an eighth of the Earth’s land surface. Will they be a cornerstone for sustaining biodiversity, or a failed experiment, overrun by humanity’s growing demands for land, food, and natural resources?

With help from more than 200 field biologists, I recently coordinated one of the largest-ever studies of the biological health of protected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies